O

Owkin

326 employees

Owkin is an AI precision medicine company with a vision to find the right drug for every patient.

Investor insights

Sectors invested in

Artificial Intelligence1
Innovation1
Software1
Digital Imaging1
Digital Pathology1
Health Care1
Cancer Diagnostic & Research1
Image Analysis1
Tele-Pathology1

Funding rounds participated in

$16M sweet spot round size

Most of their 1 investments are in rounds between $16M and $16M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
clinical data
covariate adjustment
Artificial Intelligence
digital pathology
biomarkers
clinical tools
omics technology
precision medicine
data science
oncology
biomedical images
Machine Learning
healthcare
artificial intelligence
Clinical Trials
radiology
drug discovery
real world evidence
federated learning
diagnostic solutions
real-world data
medical research

Date founded

2016

Investments made

T

TRIBVN Healthcare, Digital Pathology Solutions raised $16M on September 5, 2023

Investors: Vivalto Partners, LBO France and Owkin

Funding rounds raised

Total raised

$50M

from 14 investors over 14 rounds

O

Owkin raised $50M on June 8, 2022

Investors: Bristol-Myers Squibb, UK

O

Owkin raised $25M on May 7, 2020

Investors: Macsf, F-Prime Capital Partners, Cathay Innovation and GV

O

Owkin raised $13M on March 7, 2019

Investors: NJF Capital, Cathay Innovation, GV and F-Prime Capital Partners

O

Owkin raised $5M on May 23, 2018

Investors: GV

O

Owkin raised $11M on January 16, 2018

Investors: NJF Capital, Otium Capital and Cathay Innovation

O

Owkin raised $2.1M on October 30, 2016

Investors: NJF Capital

FAQ